These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26172928)

  • 21. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
    Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
    J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model.
    Cawston H; Maravic M; Fardellone P; Gauthier A; Kanis JA; Compston J; Borgström F; Cooper C; McCloskey E
    Arch Osteoporos; 2012; 7():237-46. PubMed ID: 23060309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and costs of osteoporotic hip fractures in Portugal.
    Vaz AL
    Bone; 1993; 14 Suppl 1():S9. PubMed ID: 8110530
    [No Abstract]   [Full Text] [Related]  

  • 24. Implications of expanding disease definitions: the case of osteoporosis.
    Herndon MB; Schwartz LM; Woloshin S; Welch HG
    Health Aff (Millwood); 2007; 26(6):1702-11. PubMed ID: 17978389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of fragility fractures in Italy.
    Ratti C; Vulcano E; La Barbera G; Canton G; Murena L; Cherubino P
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S13-4. PubMed ID: 24046040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan.
    Moriwaki K; Komaba H; Noto S; Yanagisawa S; Takiguchi T; Inoue H; Toujo T; Fukagawa M; Takahashi HE
    J Bone Miner Res; 2013 Feb; 28(2):395-403. PubMed ID: 22991163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [FRAX: building an idea to Brazil].
    Pinheiro Mde M; Camargos BM; Borba VZ; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2009 Aug; 53(6):783-90. PubMed ID: 19893924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid therapy as a significant risk factor for osteoporosis and fractures in an Italian postmenopausal population.
    Villa P; Moruzzi MC; Lassandro AP; Leoni F; Di Nardo F; De Waure C; Scambia G;
    Gynecol Endocrinol; 2013 Jul; 29(7):678-82. PubMed ID: 23638623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between low lean body mass and osteoporotic fractures after menopause.
    Capozza RF; Cure-Cure C; Cointry GR; Meta M; Cure P; Rittweger J; Ferretti JL
    Menopause; 2008; 15(5):905-13. PubMed ID: 18520697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY;
    Calcif Tissue Int; 2019 Mar; 104(3):235-238. PubMed ID: 30796490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors for osteoporosis in osteoporotic women followed in Primary Care and in Hospitals. OPINHO-PC study].
    González Macías J; Jodar E; Muñoz M; Díez Pérez A; Guañabens N; Fuster E
    Rev Clin Esp; 2009; 209(7):319-24. PubMed ID: 19709534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What are the new French recommendations for the treatment of postmenopausal osteoporosis?].
    Blain H
    Rev Med Interne; 2019 May; 40(5):275-277. PubMed ID: 29891260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epidemiology and costs of osteoporosis].
    Götte S; Dittmar K
    Orthopade; 2001 Jul; 30(7):402-4. PubMed ID: 11515176
    [No Abstract]   [Full Text] [Related]  

  • 35. Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description.
    Adami S; Bianchi G; Brandi ML; Di Munno O; Frediani B; Gatti D; Giannini S; Girasole G; Minisola G; Minisola S; Nuti R; Pedrazzoni M; Rossini M; Varenna M
    Clin Exp Rheumatol; 2010; 28(4):561-70. PubMed ID: 20497630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Osteoporotic fractures in Spanish women].
    Naves Díaz M
    Med Clin (Barc); 2006 Sep; 127(11):413-4. PubMed ID: 17020685
    [No Abstract]   [Full Text] [Related]  

  • 37. The cost of treating osteoporotic fractures in the United Kingdom female population.
    Johansen A; Stone M
    Osteoporos Int; 2000; 11(6):551-2. PubMed ID: 10982174
    [No Abstract]   [Full Text] [Related]  

  • 38. Late skeletal effects of early menopause.
    McClung MR
    Menopause; 2015 Oct; 22(10):1027-9. PubMed ID: 26397143
    [No Abstract]   [Full Text] [Related]  

  • 39. Validation of cross-sectional studies with long-term longitudinal studies.
    Cure-Cure C; Cure P
    Osteoporos Int; 2012 Jan; 23(1):399. PubMed ID: 21909726
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168].
    Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
    Eur J Cancer; 2021 Feb; 144():397-398. PubMed ID: 33353792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.